跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XOPRAZOLE PLUS - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
XOPRAZOLE PLUS
Approved
STANDARD
XOPRAZOLE PLUS
Medisure Laboratories Pakistan (Pvt)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
947b2f93f1c190dd
Company
Medisure Laboratories Pakistan (Pvt)
Type
Standard
Approval Details
Approval Id
947b2f93f1c190dd
Drug Approval Philippines Name
XOPRAZOLE PLUS
Product Name
XOPRAZOLE PLUS
Registration Number
DRP-6027
Brand Name
XOPRAZOLE PLUS
Generic Name
Omeprazole
Dosage Form
Delayed-Release capsule
Dosage Strength
40 mg
Manufacturer
Medisure Laboratories Pakistan (Pvt)
Importer
Accesspoint International Trading, Inc.
Distributor
Accesspoint International Trading, Inc.
Issuance Date
27 October 2024
Expiry Date
26 February 2030
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
947b2f93f1c190dd
Type
Standard
Back to Philippines FDA Approvals